20P Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)
Title:
20P Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)
Author:
Trigo, J. Cho, B.C. Park, K. Girard, N. Viteri, S. Garrido, P. Krebs, M.G. Thayu, M. Knoblauch, R.E. Xie, J. Bauml, J.M. Schnepp, R.W. Londhe, A. Mahadevia, P. Leighl, N.